John Palusci, Former Vice President of Transformation and Strategic Finance, BAYADA

In this episode of M&A Science, John Palusci, former Vice President of Transformation and Strategic Finance at BAYADA, joins Kison Patel to discuss how to build a repeatable, Buyer-Led M&A™ engine within a nonprofit structure. John walks through his journey from IT to finance to corporate development, detailing how he helped scale BAYADA’s deal strategy with a focus on long-term value, integration-led diligence, and mission alignment. He shares real lessons from joint ventures, cashless acquisitions, and how to avoid surprises in highly regulated industries like healthcare.

Things you will learn:

How to structure healthcare M&A for long-term mission alignment
What a “conceptual pro forma” is and why it accelerates early deal screening
How to manage integration risk in people-first, regulation-heavy industries

________________________

Sponsored by DealRoom—where M&A chaos meets its match.
Your M&A process can so much faster...
DealRoom helps corporate development teams take control—streamlining diligence, syncing integration, and eliminating the back-and-forth.

👉 Learn how you can run a repeatable, buyer-led process

_______________

Episode Chapters

[00:01:00] John’s unconventional path from IT to M&A leadership

[00:05:00] Running joint ventures with hospital systems

[00:07:30] Third-party valuation in nonprofit deals

[00:10:00] How BAYADA sourced and filtered deals

[00:13:00] Key reasons to kill a healthcare deal early

[00:16:00] How BAYADA transitioned from for-profit to nonprofit

[00:22:30] Standardizing diligence with a conceptual pro forma

[00:27:00] Managing talent transitions in home healthcare

[00:34:00] Cashless deals: how they work and when they’re possible

[00:38:30] Integration-led diligence and DealRoom’s role in execution

Questions, comments, concerns?
Follow Kison Patel for behind-the-scenes insights on modern M&A.

M&A in Healthcare with John Palusci

M&A Science

M&A in Healthcare with John Palusci